OverviewSuggest Edit

IQVIA Holdings is a global provider of analytics, technology solutions, and contract research services to the life sciences industry. The company was formed as a result of a merger between IMS Health and Quintiles.

TypePublic
Founded2016
HQDurham, US
Websiteiqvia.com
Employee Ratings3.6

Latest Updates

Employees (est.) (Dec 2019)67,000(+10%)
Job Openings3,481
Revenue (FY, 2019)$11.1 B(+7%)
Share Price (Sept 2020)$160.5
Cybersecurity ratingCMore

Key People/Management at IQVIA

Ari Bousbib

Ari Bousbib

Chairman and Chief Executive Officer
Trudy Stein

Trudy Stein

Executive Vice President and Chief Human Resources Officer
Karl Guenault

Karl Guenault

Senior Vice President and Chief Information Officer
Marla Kessler

Marla Kessler

Senior Vice President, Strategy, Marketing & Communications
Kevin Knightly

Kevin Knightly

President, Technology & Commercial Services
Jim Berkshire

Jim Berkshire

Senior Vice President, Business Operations
Show more

IQVIA Office Locations

IQVIA has offices in Durham, Alger, Buenos Aires, Melbourne and in 100 other locations
Durham, US (HQ)
4820 Emperor Blvd
Alger, DZ
Cité Sellier Coopérative Immobilière Mohamed Boudiaf N°18 1er étage Hydra
Buenos Aires, AR
7° piso, Av. Leandro N. Alem 1050
Melbourne, AU
Level 2/606 St Kilda Rd
Sydney, AU
Level 8, 201 Pacific Highway St Leonards
Wien, AT
Rund Vier B, Stella-Klein-Löw-Weg 15/Haus B 5
Show all (115)

IQVIA Financials and Metrics

IQVIA Revenue

Embed Graph
View revenue for all periods
IQVIA's revenue was reported to be $11.09 b in FY, 2019 which is a 6.5% increase from the previous period.
USD

Revenue (Q1, 2020)

2.8b

Gross profit (Q1, 2020)

930.0m

Gross profit margin (Q1, 2020), %

33.8%

Net income (Q1, 2020)

85.0m

EBIT (Q1, 2020)

193.0m

Market capitalization (17-Sept-2020)

30.7b

Closing stock price (17-Sept-2020)

160.5

Cash (31-Mar-2020)

927.0m

EV

42.2b
IQVIA's current market capitalization is $30.7 b.
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

6.9b9.7b10.4b11.1b

Revenue growth, %

42%7%6%

Cost of goods sold

4.8b6.3b6.7b7.3b

Gross profit

2.1b3.4b3.7b3.8b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

2.3b2.4b2.5b2.6b2.6b2.6b2.7b2.7b2.8b2.8b

Cost of goods sold

1.5b1.2b1.6b1.7b1.7b1.7b1.7b1.8b1.9b1.8b

Gross profit

799.0m1.2b854.0m911.0m893.0m916.0m936.0m941.0m917.0m930.0m

Gross profit Margin, %

34%51%35%36%35%35%35%34%33%34%
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

1.2b959.0m891.0m837.0m

Accounts Receivable

1.7b2.0b2.4b2.6b

Prepaid Expenses

123.0m146.0m151.0m138.0m

Current Assets

3.3b3.5b3.9b4.1b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

862.0m902.0m1.1b960.0m879.0m827.0m936.0m938.0m863.0m927.0m

Accounts Receivable

1.8b1.8b1.9b2.3b2.2b2.3b2.5b2.4b2.5b2.6b

Prepaid Expenses

134.0m153.0m146.0m148.0m158.0m154.0m153.0m180.0m150.0m173.0m

Current Assets

3.1b3.3b3.5b3.7b3.6b3.7b4.0b4.0b4.0b4.3b
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

130.0m1.3b284.0m227.0m

Depreciation and Amortization

289.0m1.0b1.1b1.2b

Accounts Payable

160.0m90.0m368.0m240.0m

Cash From Operating Activities

860.0m970.0m1.3b1.4b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

76.0m155.0m244.0m73.0m141.0m208.0m67.0m138.0m207.0m91.0m

Depreciation and Amortization

232.0m477.0m733.0m282.0m564.0m847.0m295.0m589.0m888.0m316.0m

Cash From Operating Activities

56.0m301.0m737.0m182.0m493.0m837.0m113.0m504.0m834.0m163.0m

Purchases of PP&E

(78.0m)(178.0m)(267.0m)(88.0m)(198.0m)(321.0m)(141.0m)(296.0m)(445.0m)(141.0m)
USDFY, 2016

Revenue/Employee

137.6k

Debt/Equity

0.8 x

Debt/Assets

0.3 x

Financial Leverage

2.4 x
Show all financial metrics

IQVIA Operating Metrics

IQVIA's Customers was reported to be 8 k in FY, 2019.
FY, 2016FY, 2017FY, 2018FY, 2019

Healthcare Workers

14 m15 m16 m20 m

Countries

82 83 84 100

Customers

5 k8 k8 k8 k

Data Sources

100 k120 k140 k150 k
Show all operating metrics

IQVIA Acquisitions / Subsidiaries

Company NameDateDeal Size
LinguamaticsFebruary 12, 2019
Advanced Health Media LLCMay 31, 2018
DrugDevNovember 16, 2017
Aileron SolutionsJuly 01, 2014
Novella Clinical LLCAugust 14, 2013
159 SOLUTIONS
159 Technology Solutions Private Ltd
Advanced Health Media Services
AHM Global Operations Inc.
AHM Global Services LLC
Show more

IQVIA Cybersecurity Score

Cybersecurity ratingPremium dataset

C

71/100

SecurityScorecard logo

IQVIA Revenue Breakdown

Embed Graph

IQVIA revenue breakdown by business segment: 52.2% from Research & Development Solutions, 7.3% from Contract Sales & Medical Solutions and 40.5% from Technology & Analytics Solutions

IQVIA Online and Social Media Presence

Embed Graph

IQVIA News and Updates

Pharmacovigilance Market Worth $12.25 Billion at 12.3% CAGR; Pharmaceutical Giants Such as Bayer and IQVIA to Focus on Launching Tracking Applications for PV Operations: Fortune Business Insights™

Key Companies Covered in the Pharmacovigilance Market Report Are Quanticate, Pharmaceutical Product Development, LLC, Cognizant, Parexel International Corporation, IQVIA, ICON plc, Bioclinica, Accenture plc, Covance Inc. and other key market players. Key Companies Covered in the Pharmacovigilance Ma…

Mateon Therapeutics Selects IQVIA for its Randomized, Controlled, Multi-Center Clinical Study to Test OT-101 as a Treatment for COVID-19 Patients

AGOURA HILLS, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics (OTCQB: MATN), a leading developer of TGF-β therapeutics, has selected IQVIA to manage C001, a Phase 2 randomized, controlled, multi-center clinical study of OT-101.

IQVIA Collaborates with Australian Medical Research Institute on COVID-19 Study to Support Frontline Healthcare Workers

IQVIA Collaborates with Australian Medical Research Institute on COVID-19 Study to Support Frontline Healthcare Workers

BC Platforms Closes $15 million Series C Financing and Signs Partnership with IQVIA to Extend Data Analytics in Genomics

BC Platforms, a world leader in genomic data management and analytics, today announced that it has closed a USD $15 million financing round alongside a new commercial collaboration with IQVIA™ (NYSE: IQV). The round was led by IQVIA in conjunction with Debiopharm Innovation Fund and Tesi, a Finnish …

HIMSS introduces EMEA Partner Innovation Exchange scheme, IQVIA expands operations in Ireland, and more news briefs

Also: Dutch AI startup Aidence closes €10m Series A funding round; North of Scotland Care Portal goes live; mHabitat director warns patients should be involved in the design of digital tools.

IQVIA Frequently Asked Questions

  • When was IQVIA founded?

    IQVIA was founded in 2016.

  • Who are IQVIA key executives?

    IQVIA's key executives are Ari Bousbib, Trudy Stein and Karl Guenault.

  • How many employees does IQVIA have?

    IQVIA has 67,000 employees.

  • What is IQVIA revenue?

    Latest IQVIA annual revenue is $11.1 b.

  • What is IQVIA revenue per employee?

    Latest IQVIA revenue per employee is $165.5 k.

  • Who are IQVIA competitors?

    Competitors of IQVIA include ICON, PPD and Veeva Systems.

  • Where is IQVIA headquarters?

    IQVIA headquarters is located at 4820 Emperor Blvd, Durham.

  • Where are IQVIA offices?

    IQVIA has offices in Durham, Alger, Buenos Aires, Melbourne and in 100 other locations.

  • How many offices does IQVIA have?

    IQVIA has 115 offices.